Top Markets
#1 Black Phoenix Black Phoenix +820.83%
#2 Tutorial Tutorial +25.27%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.13%
#4 Beam Beam +25.04%
#5 SAFEcoin SAFEcoin +18.55%
#6 Bless Bless +18.33%
#7 MiL.k Alliance MiL.k Alliance +17.82%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +17.38%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +15.85%
#10 THORChain THORChain +15.63%
Coin of the day
Black Phoenix Black Phoenix
設定
言語
日本
通貨
USD
テーマ
Lin BioScience, Inc. Lin BioScience, Inc.

Lin BioScience, Inc.

6696
株式のランク #5731
Lin BioScience, Inc. is an innovative biopharmaceutical company focused on... Lin BioScience, Inc. is an innovative biopharmaceutical company focused on developing novel therapies across oncology, ophthalmology, and metabolic diseases. Its robust pipeline includes LBS-008, an orally administered treatment currently in Phase 3 clinical trials for adolescent Stargardt disease (STGD1) and Phase 2/3 trials for dry age-related macular degeneration (Dry AMD), both aimed at evaluating its safety and effectiveness. Other key candidates are LBS-007, a natural non-ATP CDC7 inhibitor designed to combat various cancers; LBS-002, an anti-tubulin compound targeting primary and metastatic brain tumors; and LBS-009, an oral medication for non-alcoholic fatty liver disease and Type 2 diabetes. The company is headquartered in Taipei, Taiwan.
株価
$29.86
最終同期: 2026-08-19
時価総額
$2.48B
変化（1日）
4.92%
変化（1年）
502.82%
国
TW
取引 Lin BioScience, Inc. (6696)

カテゴリー

Healthcare
Lin BioScience, Inc.（6696）の収益
Aug 2026 時点の収益 TTM: 0
Lin BioScience, Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Lin BioScience, Inc. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH